Literature DB >> 16524552

Vaccination in patients with HIV infection.

Todd D Gleeson1, Mark R Wallace, Sybil A Tasker.   

Abstract

Although vaccine-preventable diseases are common in HIV, concerns about vaccine safety and lack of efficacy in this patient population often lead to missed opportunities for vaccination. In this article, we review the literature regarding vaccine risks and benefits and offer recommendations regarding their use and timing in patients with HIV infection.

Entities:  

Year:  2006        PMID： 16524552     DOI： 10.1007/s11908-006-0011-y

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.663


  96 in total

1.  Hepatitis A in human immunodeficiency virus-infected patients.

Authors:  M R Wallace; H E Hill; S A Tasker; L K Miller
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

2.  Measles and measles immunity in children infected with human immunodeficiency virus.

Authors:  K Krasinski; W Borkowsky
Journal:  JAMA       Date:  1989-05-05       Impact factor: 56.272

3.  Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.

Authors:  L A Jackson; J D Cherry; S P Wang; J T Grayston
Journal:  Clin Infect Dis       Date:  2000-07-17       Impact factor: 9.079

4.  Immunogenicity and tolerability of hepatitis A vaccine in HIV-infected children.

Authors:  A F T B Gouvea; M I De Moraes-Pinto; E Ono; M I S Dinelli; D M Machado; L Y Weckx; R C M Succi
Journal:  Clin Infect Dis       Date:  2005-07-14       Impact factor: 9.079

5.  Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.

Authors:  Shabir A Madhi; Locadiah Kuwanda; Leena Saarinen; Clare Cutland; Rosalia Mothupi; Helena Käyhty; Keith P Klugman
Journal:  Vaccine       Date:  2005-08-01       Impact factor: 3.641

6.  Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.

Authors:  P J Weiss; M R Wallace; E C Oldfield; J O'Brien; E N Janoff
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

7.  Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.

Authors:  Shabir A Madhi; Karen Petersen; Manikant Khoosal; Robin E Huebner; Nontombi Mbelle; Rosalia Mothupi; Haroon Saloojee; Heather Crewe-Brown; Keith P Klugman
Journal:  Pediatr Infect Dis J       Date:  2002-04       Impact factor: 2.129

8.  Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life.

Authors:  W Borkowsky; M Rigaud; K Krasinski; T Moore; R Lawrence; H Pollack
Journal:  J Pediatr       Date:  1992-03       Impact factor: 4.406

9.  Antibody response to diphtheria, tetanus, and poliomyelitis vaccines in relation to the number of CD4+ T lymphocytes in adults infected with human immunodeficiency virus.

Authors:  F P Kroon; J T van Dissel; J Labadie; A M van Loon; R van Furth
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

10.  Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

Authors:  S K Stanley; M A Ostrowski; J S Justement; K Gantt; S Hedayati; M Mannix; K Roche; D J Schwartzentruber; C H Fox; A S Fauci
Journal:  N Engl J Med       Date:  1996-05-09       Impact factor: 91.245
View more
  1 in total

1.  Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

Authors:  Nancy F Crum-Cianflone; Lynn E Eberly; Chris Duplessis; Jason Maguire; Anuradha Ganesan; Dennis Faix; Gabriel Defang; Yun Bai; Erik Iverson; Tahaniyat Lalani; Timothy Whitman; Patrick J Blair; Carolyn Brandt; Grace Macalino; Timothy Burgess
Journal:  Clin Infect Dis       Date:  2010-12-07       Impact factor: 9.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.